$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
坦罗莫司多久打一次?
2025-10-19 11:44:20
Check Details
卡博替尼(XL184)可有效改善晚期肾脏癌患者生存期
2025-10-19 11:44:20
Check Details
新发现!转移性肾癌患者应考虑基线脑成像
2025-10-19 11:44:20
Check Details
卡博替尼(XL184)在转移性肾细胞癌患者中的效果数据
2025-10-19 11:44:20
Check Details
卡博替尼(Cabozantinib)可延长患者生存期
2025-10-19 11:44:20
Check Details
卡博替尼(Cabozantinib)的安全性和耐受性及不良反应
2025-10-19 11:44:20
Check Details
2021年索坦报销后多少钱一盒
2025-10-19 11:44:20
Check Details
晚期肾癌吃索坦效果怎么样
2025-10-19 11:44:20
Check Details
如何分辨索坦和多吉美的区别
2025-10-19 11:44:20
Check Details
靶向药索拉非尼片中途停药会怎样
2025-10-19 11:44:20
Check Details
舒尼替尼(索坦)服用方法|剂量调整|副作用处理方法
2025-10-19 11:44:20
Check Details
阿西替尼2021年最新价格,阿西替尼用一个月多少钱?
2025-10-19 11:44:20
Check Details
1
2
...
8434
8435
8436
8437
8438
8439
8440
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
2
A Precision FGFR Inhibitor for Cholangiocarcinoma
3
A Revolutionary Targeted Therapy for Hematological Malignancies
4
A New Option for Advanced Renal Cell Carcinoma Treatment
5
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
6
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
7
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial
8
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
9
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
10
Avatrombopag (Doptelet) Dosage: Dose Adjustment and Medication Guidelines for Different Indications
11
Effects of Gilteritinib (Xospata) Discontinuation in Acute Myeloid Leukemia Treatment
12
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia